| Schedule of Net Loss Per Share, Basic and Diluted |
The following table sets forth reconciliation of the numerators and denominators used to compute basic and diluted net loss per share of Class A Common Stock for the years ended December 31, 2023, 2022, and 2021. The reconciliation for 2021 reflects only the period from September 15, 2021 to December 31, 2021, which represents the period wherein the Company had outstanding Class A Common Stock.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
(in thousands) |
|
December 31, 2023 |
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(289,627 |
) |
|
$ |
(24,179 |
) |
|
$ |
(62,324 |
) |
Less: Net loss attributable to Definitive OpCo before Reorganization Transactions |
|
|
— |
|
|
|
— |
|
|
|
(34,068 |
) |
Less: Net loss attributable to noncontrolling interests |
|
|
(87,239 |
) |
|
|
(16,957 |
) |
|
|
(10,416 |
) |
Net loss attributable to Definitive Healthcare Corp. |
|
$ |
(202,388 |
) |
|
$ |
(7,222 |
) |
|
$ |
(17,840 |
) |
The following table sets forth the computation of basic and diluted net loss per share of Class A Common Stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
(in thousands, except number of shares and per share amounts) |
|
December 31, 2023 |
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Basic net loss per share attributable to common stockholders |
|
|
|
|
|
|
|
|
|
Numerator: |
|
|
|
|
|
|
|
|
|
Allocation of net loss attributable to Definitive Healthcare Corp. |
|
$ |
(202,388 |
) |
|
$ |
(7,222 |
) |
|
$ |
(17,840 |
) |
Weighted average number of shares of Class A outstanding |
|
|
112,764,537 |
|
|
|
101,114,105 |
|
|
|
91,916,151 |
|
Net loss per share, basic and diluted |
|
$ |
(1.79 |
) |
|
$ |
(0.07 |
) |
|
$ |
(0.19 |
) |
|
| Schedule of Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share |
The following table presents potentially dilutive securities which were excluded from the computation of diluted net loss per share for the periods presented because their effects on net loss per share would have been anti-dilutive:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
|
|
|
December 31, 2023 |
|
|
December 31, 2022 |
|
|
December 31, 2021 |
|
Definitive OpCo units (vested and unvested) |
|
|
39,762,700 |
|
|
|
50,433,101 |
|
|
|
58,244,627 |
|
Restricted stock units |
|
|
6,828,490 |
|
|
|
3,563,387 |
|
|
|
2,100,250 |
|
|